Alpenglow Biosciences: Blandine Merino, Mike Rice

Digital pathology and 3D imaging company Alpenglow Biosciences has added Blandine Merino and Mike Rice to its advisory board. Merino previously worked at Guardant Health, where she led teams to expand the use of next-generation sequencing in clinical trials; Freenome, where she was VP of business development; and Agilent Technologies, where she led global NGS-based oncology diagnostics product strategy and development and later developed a digital pathology strategy. She holds an MS in molecular biology from the University of Paris-Saclay and an MS in engineering from ISA Graduate School in Bioengineering. Rice is the former chairman and CEO of BioLife Solutions, which he grew from fewer than 10 to more than 500 employees.